ABVC

ABVC BioPharma, Inc. Common Stock

1.08

USD

ABVC Earnings Reports

Positive Surprise Ratio

ABVC beat 3 of 8 last estimates.

38%

Next Report

Date of Next Report

Apr 13, 2026

Estimate for Q4 25 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

ABVC BioPharma, Inc. Common Stock earnings per share and revenue

On --, ABVC reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Dyadic International, Inc.

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.04

Actual

-$0.06

Surprise

-30.72%

TELA Bio, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.18

Actual

-$0.16

Surprise

+14.12%

BioCardia, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.17

Actual

-$0.06

Surprise

+65.40%

Celcuity Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$1.06

Actual

-$0.97

Surprise

+8.72%

Precigen, Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.01

Surprise

+88.24%

Absci Corporation Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.19

Actual

-$0.23

Surprise

-16.04%

Candel Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.25

Actual

-$0.54

Surprise

-115.31%

LENZ Therapeutics, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.99

Actual

-$1.15

Surprise

-17.10%

Fennec Pharmaceuticals Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

$0.03

Actual

-$0.11

Surprise

-408.12%

Equillium, Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.06

Actual

-$0.04

Surprise

+35.28%

FAQ

What were ABVC BioPharma, Inc. Common Stock's earnings and revenue for the latest quarter Q-- --?

For Q-- --, ABVC BioPharma, Inc. Common Stock reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.

How did the market react to ABVC BioPharma, Inc. Common Stock's Q-- -- earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is ABVC BioPharma, Inc. Common Stock expected to report next?

The next earning report is scheduled for Apr 13, 2026.

What are the forecasts for ABVC BioPharma, Inc. Common Stock's next earnings report?

Based on -- analysts, ABVC BioPharma, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.